Return to previous page |
Standardisation
Burns C, Rigsby P, Moore M and Rafferty B (2009) First International Standard for Insulin-like Growth Factor-1 (IGF-1) for immunoassay: Preparation and Calibration in an International Collaborative Study. Growth Hormone and IGF Research 19: 457-462.
Sturgeon C, Berger P, Bidart J-M, Birken S, Burns C, Norman R, Stenman U-H (2009) Recognition of the 1st International Reference Reagents for hCG-related isoforms by diagnostic immunoassays for hCG: A source of between-assay differences. Clinical Chemistry 55: 1484-1491.
Behr-Gross M-E, Daas A, Burns C, Bristow AF (2007) Collaborative Study for the Establishment of Erythropoetin BRP Batch 3. Pharmeuropa BIO 2007-1: 49-66.
Research and Development
Burns CJ, Courtney ML, Persaud SJ and Jones PM (2009) Stem cell Therapy for Type 1 diabetes mellitus. In Diabetes Mellitus Research Advances. Ed Maximillian N Huber (in press).
Courtney ML, Jones PM and Burns CJ (2009) The importance of quantitative analysis in the generation of insulin-expressing cells from human embryonic stem cells. Pancreas (in press).
Moore M, Meager A, Wadhwa M and Burns CJ (2008) Measurement of neutralising antibodies to type I interferons by gene expression assays specific for type 1 interferon-inducible 6-16 mRNA. Journal of Pharmaceutical and Biomedical Analysis 49:534-9.
Kitsou-Mylona I, Burns CJ, Squires PE, Persaud SJ, Jones PM (2008) The extracellular calcium-sensing receptor is involved in cell-cell communication in pancreatic islets of Langerhans. Cellular Physiology and Biochemistry 22: 557-66.
Jones PM, Courtney ML, Burns CJ and Persaud SJ (2008) Cell-based treatments for diabetes. Drug Discovery Today 13: 888-893
Silva MM, Lamarre B, Cerasoli E, Rakowska P, Hills A, Bailey MJAB, Wheeler J, Burns CJ, Gaines-Das R, Jones C, Robinson CJ (2008) Physicochemical and biological assays for quality control of biopharmaceuticals: Interferon alfa-2 case study. Biologicals 36: 383-92.
Burns CJ, Silva MM, Gray E and Robinson CJ (2008) Quantitative RT-PCR as an alternative to late-stage bioassays for vascular endothelial growth factor. Journal of Pharmaceutical and Biomedical Analysis 47: 460–468.